Recent studies of antileprosy drugs.
D000818:Animals; D003523:Cycloserine / Q000031:analogs & derivatives; D004338:Drug Combinations / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical; D004977:Ethambutol / Q000494:pharmacology; D005000:Ethionamide / Q000031:analogs & derivatives; D007538:Isoniazid / Q000031:analogs & derivatives / Q000494:pharmacology; D007917:Leprostatic Agents / Q000494:pharmacology*; D051379:Mice; D009166:Mycobacterium leprae / Q000187:drug effects*; D011515:Prothionamide / Q000031:analogs & derivatives; D013329:Structure-Activity Relationship; D013450:Sulfones / Q000494:pharmacology; D013882:Thiosemicarbazones / Q000494:pharmacology
D004338:Drug Combinations; D007917:Leprostatic Agents; D013450:Sulfones; D013882:Thiosemicarbazones; C038883:isoetam; D011515:Prothionamide; D004977:Ethambutol; D003523:Cycloserine; D005000:Ethionamide; D007538:Isoniazid